| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |